Seah H. Lim, M.D., Ph.D. 13D and 13G filings for Emmaus Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-04 11:00 am Sale | 2024-12-31 | 13G | Emmaus Life Sciences, Inc. EMMA | Seah H. Lim, M.D., Ph.D. | 4,147,426 6.500% | -439,200 (-9.58%) | Filing |
| 2023-12-22 5:30 pm Purchase | 2023-12-18 | 13G | Emmaus Life Sciences, Inc. EMMA | Seah H. Lim, M.D., Ph.D. | 4,586,626 7.400% | 4,586,626 (New Position) | Filing |